Esmolol + Metoprolol
ApprovedTerminated 0 watching 0 views this week๐ฅ Hot
82
Development Stage
โ
Pre-clinicalโ
Phase 1โ
Phase 2โ
Phase 35
ApprovedIndication / Disease
Vascular Disease
Conditions
Vascular Disease, Hypertension, Angina, Cardiac Disease
Trial Timeline
Apr 1, 2011 โ Dec 1, 2013
NCT ID
NCT01404767About Esmolol + Metoprolol
Esmolol + Metoprolol is a approved stage product being developed by Baxter for Vascular Disease. The current trial status is terminated. This product is registered under clinical trial identifier NCT01404767. Target conditions include Vascular Disease, Hypertension, Angina.
Hype Score Breakdown
Clinical
30
Activity
20
Company
7
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01404767 | Approved | Terminated |
Competing Products
20 competing products in Vascular Disease